Allocure
Latest round
- Series B
Last raised
- Apr 2012
Total raised
- $40M
Investors
- 4
About Allocure
AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.
Who invested in Allocure
4 investors across 2 rounds
See all investors in Allocure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allocure
Who invested in Allocure?
Allocure has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allocure raised?
Allocure has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allocure last raise money?
Allocure's most recent round on record is a Series B, in Apr 2012.
What does Allocure do?
AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.
Where is Allocure headquartered?
Allocure is headquartered in Burlington, US.
Which VCs invest in companies like Allocure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allocure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Allocure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.